Literature DB >> 9139772

National and international guidelines for the diagnosis and treatment of asthma.

R A Nicklas.   

Abstract

Excellent guidelines on the management of asthma are now available. The most comprehensive guidelines developed recently are the National Heart, Lung, and Blood Institute (NHLBI) Guidelines for the Diagnosis and Management of Asthma, the NHLBI/World Health Organization Global Initiative for Asthma, and the American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma and Immunology Practice Parameters for the Diagnosis and Treatment of Asthma. The main purpose of such guidelines is to improve the quality of care for patients with asthma. This can only be accomplished, however, if these documents are used effectively.

Entities:  

Mesh:

Year:  1997        PMID: 9139772     DOI: 10.1097/00063198-199701000-00008

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  9 in total

1.  Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene.

Authors:  C Brasch-Andersen; Q Tan; A D Børglum; A Haagerup; T R Larsen; J Vestbo; T A Kruse
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

2.  Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma.

Authors:  J P Kemp
Journal:  Drugs       Date:  2000       Impact factor: 9.546

3.  Asthma management by medical practitioners: the situation in a developing country.

Authors:  Osarogiagbon Wilson Osaretin; Nwaneri Damian Uchechukwu; Oviawe Osawaru
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

4.  Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma.

Authors:  R J Ozminkowski; S Wang; W D Marder; J Azzolini; D Schutt
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

Review 5.  A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.

Authors:  Frank Kässner; Rick Hodder; Eric D Bateman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases.

Authors:  C Brasch-Andersen; A Haagerup; A D Børglum; J Vestbo; T A Kruse
Journal:  J Med Genet       Date:  2006-03       Impact factor: 6.318

7.  Expression, cloning, and IgE-binding of the full-length dust mite allergen Der f 8.

Authors:  Yu-Bao Cui; Ying Zhou; Nan Wang; Fei-Xiang Teng; Li-Li Yu; Yong-Hua Bian; Jin-Xia Song; Li Yang; Cheng-Bo Zhang
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 8.  Practice parameters in pediatric allergy.

Authors:  Richard A Nicklas
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

9.  Expression, epitope prediction and IgE-binding of the Tyrophagus putrescentiae group 13 allergen.

Authors:  Nan Wang; Ying Zhou; Meili Wu; Hanting Zhu; Yubao Cui
Journal:  Exp Ther Med       Date:  2020-08-27       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.